Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., March 8, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, March 15, 2018, at 4:30 p.m. ET to review its fourth quarter and full year 2017 financial results and provide an update on the company.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 5558799. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com

SOURCE Infinity Pharmaceuticals, Inc.

These press releases may also interest you

at 19:24
As an air ambulance service provider, Northern Air is concerned AHS and Minister of Health Sarah Hoffman believe removing one of two air ambulance aircraft from Peace River is an improvement in this critical service. Northern Air President Nate...

at 18:00
The Society of Interventional Radiology Foundation presented this year's Frederick S. Keller, M.D., Philanthropy Award posthumously to Constantin Cope, M.D., FSIR, at the foundation's annual Gala on March 18, held in conjunction with the Society of...

at 15:15
The Honourable Ginette Petitpas Taylor, Federal Minister of Health, and the Parliamentary Secretary to the Minister of Justice and Attorney General of Canada and to the Minister of Health, Bill Blair, will hold a media availability in the Foyer of...

at 15:00
Harnessing the innovative spirit that launched interventional radiology is key to ensuring the specialty's continued evolution and expansion, said Timothy P. Murphy, M.D., FSIR, who delivered the Society of Interventional Radiology's (SIR) 2018 Dr....

at 13:30
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to Karim Valji, M.D., FSIR; John A. Kaufman, M.D., M.S., FSIR; and Renate L. Soulen, M.D., FSIR, during its Annual Scientific Meeting in Los Angeles. These...

at 11:30
Efficacy and Tolerability Results With Oncofid®P-B in Patients With Papillary Bladder Cancer No new drug treatments for primary or recurrent papillary bladder cancer in 15 years Oncofid®P-B is a Paclitaxel-Hyaluronan Bioconjugate developed and...

News published on 8 march 2018 at 16:05 and distributed by: